Please login to the form below

Not currently logged in
Email:
Password:

Anti-trust inquiry: Merck, Schering-Plough

The US FTC has requested that Merck & Co and Schering-Plough must provide additional information regarding their $41.1bn merger

The US Federal Trade Commission (FTC) has requested that Merck & Co and Schering-Plough must provide additional information regarding their $41.1bn merger.

The query is mostly about the company's animal-health units and was reportedly "anticipated" by the New Jersey-based drugmakers which still plan to close the deal this year.

On June 3, Merck said that it planned to sell one of the companies' animal health units to help fund the acquisition and reduce overlap. If a sale doesn't settle FTC concerns about competition in the animal drug industry, Merck or Schering-Plough may have to put more products on the market.

Analyst David Moskowitz of Caris & Co said: "There's going to be many more products for sale. It could affect pricing in the sense that Merck really wants to get those approvals." He added that antitrust concerns are unlikely to prevent the merger. "Merck absolutely needs to get this done to produce growth over the next couple of years." 

23rd June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics